Forks over Knives • 2011

39:21

Both the Greek island of Ikaria and a peninsula in Costa Rica boast some of the world's healthiest and most active folks over 100 years old. Discover how they do it with simple foods and exercise that are fully integrated into daily life.

S1E3 • Live to 100: Secrets of the Blue Zones • 2023 • Health

117:55

Filmed over six years following a group of volunteers with Parkinson's disease as they take part in a ground-breaking medical trial to test a new drug that could be the first to halt progression or even reverse their condition.

2019 • Health

58:59

After being diagnosed with a rare and deadly form of malignant melanoma - acral lentiginous melanoma - Dr George McGavin embarks on a highly emotional and deeply personal journey as he goes through treatment for his cancer. George’s treatment is targeted drug therapy, using drugs approved for use by the NHS only weeks before his diagnosis. During this journey, he is given unprecedented access to the process and science behind his medical treatment and diagnosis. He also meets some of the most highly regarded scientists in the field of cancer research in his quest to understand not just his disease but what the future holds as a whole for cancer treatment. Amongst them are Professor Sir Michael Stratton, director of the Wellcome Sanger Institute and chief executive officer of the Wellcome Genome Campus, whose work resulted in the discovery of the mutation in the B RAF gene responsible for his form of melanoma. George also travels to Houston, Texas to meet Professor James P Allison, winner of the 2018 Nobel Prize in Medicine, to find out about his pioneering work in the field of immunotherapy - the greatest breakthrough in cancer research in a century. Back home in his own hospital, he meets a unique group of stage four melanoma patients who owe their lives to Professor Allison’s work. Ultimately, his journey culminates when he receives his prognosis, after three months of treatment, which will determine his future. Will these groundbreaking drugs actually work?

2019 • Health

59:03

Dr Chris van Tulleken, Dr Hannah Fry and Michael Mosley examine the latest research and explore some of the big questions about Covid-19 and the pandemic it has created. Michael visits the UK government's high-security laboratory Porton Down, where vaccines are being tested. He also uncovers what the experience of the 2002 SARs epidemic reveals about this one. Both were caused by coronaviruses, but certain key changes to today's virus have allowed it to infect the world, where SARs was contained.

Horizon • 2020 • Health

58:54

Fresh or processed, white or red - how does meat measure up? It's been getting a lot of bad press recently with new links to cancer and heart disease. But 98 per cent of us in the UK are still meat eaters. Chris Bavin, a greengrocer by trade and a carnivore by nature, wants to know if he can keep meat in his diet and stay healthy. He teams up with top scientists to put meat under the microscope and examine it as never before. They follow 40 volunteers on a groundbreaking study to find out exactly how much meat is good for us, test whether paying more for chicken makes it any better for us, discover a way to dramatically reduce the health risks associated with processed meats and reveal an unlikely lean supermeat that won't break the bank.

2016 • Health

100:14

Follows two patients through groundbreaking 'first in-human' trials for CAR T-cell therapy, a treatment described as the beginning of the end of cancer. Not allowed to meet and separated by two floors of a hospital, 53-year-old Graham and 18-year old-Mahmoud are nevertheless bound together by their commitment to the treatment and their faith in the science. Terminally ill, the trial represents their only option. How do their ages and life experiences affect their physical and emotional response? For Martin Pule, the scientist who has developed the treatment, the responsibility of curing patients is both exciting and daunting. He knows he stands on the cusp of a breakthrough that could radically change the way we treat cancer. At the heart of this film is the complex relationship between the patients and the clinical team. How much hope can the patients be given when they are effectively going into these trials as human guinea pigs? The patients and clinical team must weigh up hope with realism and their response is a profound and revealing reflection of the human condition.

2019 • Health